US 10596132
Solid solution compositions and use in chronic inflammation
granted A61KA61K31/12A61K31/121
Quick answer
US patent 10596132 (Solid solution compositions and use in chronic inflammation) held by Infirst Healthcare Limited expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Infirst Healthcare Limited
- Grant date
- Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/12, A61K31/121, A61K31/192, A61K31/196